Broadfin Capital’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$7.77M Sell
1,029,012
-2,073,661
-67% -$15.7M 1.04% 24
2019
Q3
$12.9M Hold
3,102,673
2.39% 10
2019
Q2
$8.97M Hold
3,102,673
1.95% 15
2019
Q1
$4.47M Hold
3,102,673
0.92% 33
2018
Q4
$8.01M Buy
3,102,673
+309,900
+11% +$800K 1.05% 24
2018
Q3
$12.3M Buy
2,792,773
+68,110
+2% +$299K 1.8% 18
2018
Q2
$16.7M Buy
2,724,663
+100,000
+4% +$613K 2.63% 13
2018
Q1
$19.1M Buy
2,624,663
+32,942
+1% +$240K 2.98% 12
2017
Q4
$21.3M Sell
2,591,721
-976,401
-27% -$8.01M 3.47% 13
2017
Q3
$37.5M Sell
3,568,122
-565,342
-14% -$5.94M 5.54% 5
2017
Q2
$45.6M Sell
4,133,464
-261,000
-6% -$2.88M 5.54% 4
2017
Q1
$42.5M Hold
4,394,464
5.15% 4
2016
Q4
$45.7M Hold
4,394,464
5.07% 5
2016
Q3
$54.5M Hold
4,394,464
4.88% 5
2016
Q2
$47.2M Hold
4,394,464
4.59% 5
2016
Q1
$48.5M Hold
4,394,464
4.69% 3
2015
Q4
$53.7M Hold
4,394,464
3.3% 7
2015
Q3
$71.7M Sell
4,394,464
-580,720
-12% -$9.47M 3.99% 3
2015
Q2
$105M Buy
4,975,184
+255,225
+5% +$5.41M 5.67% 2
2015
Q1
$84.9M Sell
4,719,959
-433,231
-8% -$7.79M 6.61% 2
2014
Q4
$88.3M Buy
5,153,190
+147,577
+3% +$2.53M 7.68% 2
2014
Q3
$71.6M Sell
5,005,613
-262,298
-5% -$3.75M 7.51% 1
2014
Q2
$79M Hold
5,267,911
7.71% 1
2014
Q1
$70.6M Buy
5,267,911
+1,500,000
+40% +$20.1M 6.84% 1
2013
Q4
$30.3M Hold
3,767,911
4% 7
2013
Q3
$24.7M Buy
3,767,911
+628,780
+20% +$4.12M 4.39% 6
2013
Q2
$19.3M Buy
+3,139,131
New +$19.3M 3.77% 9